celsentri
glaxosmithkline nz limited - maraviroc 150mg; - film coated tablet - 150 mg - active: maraviroc 150mg excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose opadry blue 85g20583 sodium starch glycolate - celsentri, in combination with other antiretroviral medicinal products, is indicated for adult patients infected with only ccr5-tropic hiv-1. the use of other active agents with celsentri is associated with a greater likelihood of treatment response.
celsentri
glaxosmithkline nz limited - maraviroc 300mg; - film coated tablet - 300 mg - active: maraviroc 300mg excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose opadry blue 85g20583 sodium starch glycolate - celsentri, in combination with other antiretroviral medicinal products, is indicated for adult patients infected with only ccr5-tropic hiv-1. the use of other active agents with celsentri is associated with a greater likelihood of treatment response.
celsentri 150 mg
glaxo smith kline (israel) ltd - maraviroc - film coated tablets - maraviroc 150 mg - maraviroc - maraviroc - celsentri is a ccr5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only ccr5-tropic hiv-1.• in treatment-naïve subjects, more subjects treated with celsentri experienced virologic failure and developed lamivudine resistance compared to efavirenz.• tropism testing with a highly sensitive tropism assay is required for the appropriate use of celsentri.
celsentri 300 mg
glaxo smith kline (israel) ltd - maraviroc - film coated tablets - maraviroc 300 mg - maraviroc - maraviroc - celsentri is a ccr5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only ccr5-tropic hiv-1.• in treatment-naïve subjects, more subjects treated with celsentri experienced virologic failure and developed lamivudine resistance compared to efavirenz.• tropism testing with a highly sensitive tropism assay is required for the appropriate use of celsentri.
stieva-a cream
glaxosmithkline inc - tretinoin - cream - 0.05% - tretinoin 0.05% - cell stimulants and proliferants
stieva-a cream
glaxosmithkline inc - tretinoin - cream - 0.025% - tretinoin 0.025% - cell stimulants and proliferants
stieva-a solution
glaxosmithkline inc - tretinoin - solution - 0.025% - tretinoin 0.025% - cell stimulants and proliferants
stieva-a gel
glaxosmithkline inc - tretinoin - gel - 0.025% - tretinoin 0.025% - cell stimulants and proliferants
stieva-a gel
glaxosmithkline inc - tretinoin - gel - 0.05% - tretinoin 0.05% - cell stimulants and proliferants
stieva-a cream
glaxosmithkline inc - tretinoin - cream - 0.01% - tretinoin 0.01% - cell stimulants and proliferants